Efficacy and Safety of Dex-Methylphenidate Extended Release 30 mg Versus 20 mg in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting.
PHASE4
This study will evaluate the efficacy and safety of Dex-Methylphenidate Ext...
Efficacy and Safety Study of Methylphenidate Hydrochloride Extended Release in Adults With Childhood-onset Attention Deficit/Hyperactivity Disorder (ADHD)
PHASE3
This study will evaluate efficacy and safety of methylphenidate hydrochlori...
A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder
PHASE2
The primary purpose of your child's participation in this study is to deter...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.